Search > Bone Cancer
My employer runs this trial

LX-101 for Ewing Sarcoma

JL
Overseen ByJoseph Ludwig, MD
Age: Any Age
Sex: Any
Trial Phase: Phase 2
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical research study is to learn if new anticancer drugs or drug combinations can help to control relapsed/refractory ES, DSRCT, or SRCS.

Who Is on the Research Team?

JL

Joseph Ludwig, MD

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

Inclusion Criteria

I have a tumor that is at least 1 cm in size and can be measured on scans.
My cancer has come back or did not respond to chemotherapy.
I have had at least two different chemotherapy treatments.
See 3 more

Exclusion Criteria

Known personal or family history of Long QT syndrome
I have not had major surgery or an open wound in the past 28 days.
Psychiatric illness or social situations limiting compliance with study requirements
See 7 more

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Treatment with LX-101Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.